Ambient Temperature and Thermoregulation During Exercise in Children and Youth
1 other identifier
interventional
12
1 country
1
Brief Summary
Little is known about how children and youth regulate body temperature during exercise across different environmental temperatures compared with young adults, including whether differences in whole-body heat exchange contribute to their responses. The goal of this clinical trial is to determine how ambient temperature affects thermoregulation during exercise in boys and girls aged 9-16 years compared with young adult men and women aged 20-25 years. Participants will complete four study visits at ambient temperatures of 22°C (Celsius; 72°F, Fahrenheit), 26°C (79°F), 31°C (88°F), and 36°C (97°F), while exercising at the same moderate-intensity metabolic heat production of 160 W/m² (W = watts, m = meters). During each visit, participants will complete four 15-minute periods of exercise (exercise bouts 1, 2, 3 and 4 respectively) separated by 15-minute rest periods. Testing will be performed in a whole-body air calorimeter, a specialized chamber that precisely measures heat lost through evaporation and dry heat exchange and the amount of heat stored in the body. These measurements, together with core temperature and heart rate, will allow researchers to determine how increasing ambient temperature affects the body's ability to lose heat and whether these responses differ between children and youth and young adults.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jul 2026
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 19, 2026
CompletedFirst Submitted
Initial submission to the registry
August 18, 2026
CompletedFirst Posted
Study publicly available on registry
August 24, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 30, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
June 30, 2027
August 24, 2026
August 1, 2026
10 months
August 18, 2026
August 20, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Core temperature
Core temperature indexed by visceral (telemetry pill) temperature
End of each of the four 15 minutes exercise bouts (average of last 5 minutes)
Secondary Outcomes (8)
Evaporative heat loss
End of each of the four 15 minutes exercise bouts (average of last 5 minutes)
Dry heat loss
End of each of the four 15 minutes exercise bouts (average of last 5 minutes)
Whole-body total heat loss
End of each of the four 15 minutes exercise bouts (average of last 5 minutes)
Body heat storage
Change from start to end of exercise for each of the four 15 minutes exercise bouts
Skin temperature
End of each of the four 15 minutes exercise bouts (average of last 5 minutes)
- +3 more secondary outcomes
Study Arms (4)
Exercise at 22°C
EXPERIMENTALParticipants will complete intermittent moderate-intensity exercise at an ambient temperature of 22°C (celsius; 72°F, fahrenheit). Exercise will be performed at a metabolic heat production of 160 W/m² (W = watts, m = meters) and will consist of four 15-minute exercise periods separated by 15-minute rest periods. Exercise workload will be individually adjusted to achieve the prescribed metabolic heat production.
Exercise at 26°C
EXPERIMENTALParticipants will complete intermittent moderate-intensity exercise at an ambient temperature of 26°C (79°F). Exercise will be performed at a metabolic heat production of 160 W/m² and will consist of four 15-minute exercise periods separated by 15-minute rest periods. Exercise workload will be individually adjusted to achieve the prescribed metabolic heat production.
Exercise at 31°C
EXPERIMENTALParticipants will complete intermittent moderate-intensity exercise at an ambient temperature of 31°C (88°F). Exercise will be performed at a metabolic heat production of 160 W/m² and will consist of four 15-minute exercise periods separated by 15-minute rest periods. Exercise workload will be individually adjusted to achieve the prescribed metabolic heat production.
Exercise at 36°C
EXPERIMENTALParticipants will complete intermittent moderate-intensity exercise at an ambient temperature of 36°C (97°F). Exercise will be performed at a metabolic heat production of 160 W/m² and will consist of four 15-minute exercise periods separated by 15-minute rest periods. Exercise workload will be individually adjusted to achieve the prescribed metabolic heat production.
Interventions
Participants complete intermittent exercise at a metabolic heat production of 160 W/m² in an ambient temperature of 22°C (72°F).
Participants complete intermittent exercise at a metabolic heat production of 160 W/m² in an ambient temperature of 26°C (79°F).
Participants complete intermittent exercise at a metabolic heat production of 160 W/m² in an ambient temperature of 31°C (88°F).
Participants complete intermittent exercise at a metabolic heat production of 160 W/m² in an ambient temperature of 36°C (97°F).
Eligibility Criteria
You may qualify if:
- Healthy male or female.
- Aged 9-16 years or 20-25 years.
- Habitually active, defined as participating in regular physical activity at least 3 times per week for at least 20 minutes per session over the previous 6 months.
- Able to understand and communicate in English or French.
- For participants younger than 18 years, written parental or guardian consent and participant assent are required.
You may not qualify if:
- Acute illness at the time of testing (e.g., cold, flu, or infection).
- History of a chronic medical condition that may affect thermoregulation, cardiovascular function, or exercise capacity (e.g., cardiovascular disease, metabolic disorders, respiratory disease including asthma requiring regular medication, or neurological disorders).
- Use of medications known to affect thermoregulation, hydration status, or cardiovascular responses.
- History of heat-related illness (e.g., heat exhaustion or heat stroke).
- Digestive abnormalities or gastrointestinal conditions that may contraindicate ingestion of a telemetry pill.
- Any condition that, in the opinion of the investigators, would compromise participant safety or the integrity of the data.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Ottawa
Ottawa, Ontario, K1N 6N5, Canada
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- BASIC SCIENCE
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Full Professor
Study Record Dates
First Submitted
August 18, 2026
First Posted
August 24, 2026
Study Start
July 19, 2026
Primary Completion (Estimated)
April 30, 2027
Study Completion (Estimated)
June 30, 2027
Last Updated
August 24, 2026
Record last verified: 2026-08